BioLife Solutions Inc.

NASDAQ: BLFS · Real-Time Price · USD
25.14
-0.18 (-0.71%)
At close: Aug 15, 2025, 10:02 AM

BioLife Solutions Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
25.42M 23.94M -3.42M 30.57M 28.33M 18.43M 32.73M 23.57M 39.51M 37.7M 44.26M 40.75M 40.53M 36.22M 37.3M 33.8M 31.2M 16.85M
Cost of Revenue
8.04M 8.15M -11.7M 8.77M 13.44M 20.08M 24.4M 21.68M 27.7M 23.66M 30.29M 27.01M 26.19M 24.45M 30.44M 24.86M 18.55M 7.55M
Gross Profit
17.39M 15.79M 8.27M 21.81M 14.89M 11.65M 8.34M 11.99M 11.81M 14.04M 13.97M 13.74M 14.34M 11.77M 6.86M 8.94M 12.65M 9.3M
Operating Income
-15.84M -1.22M 1.39M -1.56M -2.79M -3.29M -7.45M -8.74M -15.28M -12.88M -10.21M -9.06M -8.72M -10.96M -18.18M -11.16M -4.55M -981K
Interest Income
n/a 681K n/a n/a n/a n/a n/a n/a n/a n/a 506K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-15.71M -434K 1.54M -1.73M -7.15M -3.18M -7.25M -15.69M -10.19M -13.62M -49.28M -10.56M -76.29M -7.67M -17.99M -4.91M -4.68M -1.12M
Net Income
-15.84M -448K 12.46M -1.7M -20.72M -10.22M -13.38M -29.13M -10.2M -13.71M -49.19M -9.96M -72.55M -7.07M -15.22M 79K 7.88M -1.12M
Selling & General & Admin
14.13M 14.1M 5.8M 14.89M 14.4M 18M 17.51M 15.69M 21.72M 21.31M 18.56M 16.86M 16.77M 16.09M 16.81M 14.15M 10.29M 6.85M
Research & Development
2.72M 2.2M 1.08M 2.05M 2.38M 3.53M 4.4M 5.4M 4.84M 4.15M 4.16M 3.42M 3.43M 3.78M 3.57M 3.22M 3.04M 1.99M
Other Expenses
17.18M 702K 3K 6.42M 910K n/a n/a 6.38M 390K 1.46M 1.46M 2.51M 2.86M 2.86M 299K -7K -121K -16K
Operating Expenses
34.03M 17M 6.88M 23.36M 17.69M 21.54M 21.91M 27.47M 28.01M 26.92M 24.18M 22.8M 23.06M 22.73M 23.24M 19.89M 15.21M 9.77M
Interest Expense
684K n/a -116K 267K 361K 207K 507K 476K 387K 411K 438K 15K 32K 184K 101K 194K 121K 16K
Selling & Marketing Expenses
2.73M 2.6M -791K 3.54M 3.5M 2.38M 4.54M 4.88M 6.32M 6.47M 5.99M 5.28M 5.42M 4.89M 4.77M 4.07M 3.14M 2.02M
Cost & Expenses
42.06M 25.16M -4.81M 32.13M 31.12M 21.73M 46.3M 39.05M 55.71M 50.59M 54.47M 49.8M 49.25M 47.18M 53.68M 44.75M 33.77M 17.32M
Income Tax Expense
126K 14K -131K -28K 1K 17K -43K 115K 5K 92K -86K -599K -3.74M -599K -2.77M -4.99M -12.55M n/a
Shares Outstanding (Basic)
47.8M 47.13M 46.65M 46.18M 46M 45.43M 44.82M 43.57M 43.44M 43.03M 42.79M 42.65M 42.46M 42.01M 41.68M 40.91M 38.07M 33.24M
Shares Outstanding (Diluted)
47.8M 47.13M 48.03M 46.18M 46M 45.43M 44.82M 43.57M 43.44M 43.03M 42.79M 42.65M 42.46M 42.01M 41.68M 43.3M 40.39M 33.24M
EPS (Basic)
-0.33 -0.01 0.27 -0.04 -0.45 -0.22 -0.3 -0.67 -0.23 -0.32 -1.15 -0.23 -1.72 -0.18 -0.37 0.00 0.20 -0.03
EPS (Diluted)
-0.33 -0.01 0.26 -0.04 -0.45 -0.22 -0.3 -0.67 -0.23 -0.32 -1.15 -0.23 -1.72 -0.18 -0.37 0.00 0.19 -0.03
EBITDA
-15.84M 166K 6.75M 853K 1.54M -7.61M -10.54M -24.8M -6.71M -9.61M -6.76M -6.53M -71.03M -2.8M -12.2M -7.29M -918K 1.24M
EBIT
-15.71M -1.22M 5.04M -1.46M -825K -3.04M -12.92M -28.54M -5.13M -13.21M -11.18M -10.9M -76.28M -7.84M -15.44M -10.95M -4.55M -1.1M
Depreciation & Amortization
1.38M 1.38M 1.7M 2.32M 2.36M 2.28M 2.38M 3.74M 3.06M 3.6M 5.71M 4.03M 5.25M 5.04M 4.75M 4.41M 3.64M 2.12M